5-Fluorouracil-β-Cyclodextrin conjugates:Linker strategies to enhance the anticancer efficacy and reduce the side effects
5-Fluorouracil (5-FU) serves as a first-line therapeutic agent for colorectal cancer, however, its utility is limited by a short half-life and significant cytotoxicity. This study focused on the construction of 5-Fluorouracil-β-Cyclodextrin polymers (5-FUSA-β-CD and 5-FUBA-β-CD) by covalent conjugat...
Saved in:
Main Authors: | Liangliang Hu, Ting Meng, Davies Marabada, Zhichao Jin, Qing Huang, Shijie Wei, Zhizhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Carbohydrate Polymer Technologies and Applications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666893925000301 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determination of 5-fluorouracil anticancer drug solubility in supercritical CO 2 using semi-empirical and machine learning models
by: Gholamhossein Sodeifian, et al.
Published: (2025-02-01) -
AN EXAMINATION OF CONJUGATIONAL SUFFIXES OF PASSIVE CONSTRUCTIONS IN FULFULDE
by: YAHAYA MOHAMMED AHMED
Published: (2024-07-01) -
Repetitive stability study of remdesivir/cyclodextrin complex on the international space station
by: György Dormán, et al.
Published: (2025-02-01) -
Current issues with antibody-conjugated lipid nanoparticles
by: Aayush
Published: (2025-02-01) -
Phenotypic and genotypic features of the full-term newborns with delayed conjugation jaundices in relation to gender of the child
by: O. K. Botvin'yev, et al.
Published: (2013-12-01)